{"nct_id":"NCT05605899","title":"Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2023-02-10","start_date_type":"ACTUAL","primary_completion_date":"2031-03","primary_completion_date_type":"ESTIMATED","completion_date":"2031-03","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GILD"]}